EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, modest growth trend.
Left:
||||
Enterprise value to sales ratio
Latest
7.89
↓ 36% below average
Average (9y)
12.29
Historical baseline
Range
High:45.79
Low:1.96
CAGR
+9.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 7.89 | -39.4% |
| 2023 | 13.03 | +563.5% |
| 2022 | 1.96 | -65.9% |
| 2021 | 5.76 | +146.1% |
| 2020 | 2.34 | -74.9% |
| 2019 | 9.33 | -63.0% |
| 2018 | 25.22 | +212.5% |
| 2017 | 8.07 | -82.4% |
| 2016 | 45.79 | +1227.5% |
| 2015 | 3.45 | - |